Citation Impact

Citing Papers

In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging
2011
Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
2008
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers
2007
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Breast cancer
2019 Standout
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
2007
The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
2018
Astrocytes: biology and pathology
2009 Standout
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study
2009
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Pancreatic cancer
2004 Standout
Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of Neurotoxicity
2011
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
2009
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
2010
Burden of liver diseases in the world
2018 Standout
Guillain-Barré syndrome
2016 Standout
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials
2019
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
2018
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
2010
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
2012
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
2017 StandoutNature
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
2007
The Challenges of Colorectal Cancer Survivorship
2009
Acute Pancreatitis
2016 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Senescent mesenchymal cells accumulate in human fibrosis by a telomere‐independent mechanism and ameliorate fibrosis through matrix metalloproteinases
2010
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy
2010
Toxicity of platinum compounds
2003
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties
2013
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
2011
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Detailed fluid resuscitation profiles in patients with severe acute pancreatitis
2010
HFE-associated hereditary hemochromatosis
2009
CD4+T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells–novel implications of CD4+T cells in pancreatic cancer development
2015
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Treatment of unresectable cholangiocarcinoma using yttrium‐90 microspheres
2008
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Neurological adverse effects caused by cytotoxic and targeted therapies
2009
Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
2009
Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation
2017
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
2013 StandoutNobel
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy
2010
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
The pancreatic stellate cell: a star on the rise in pancreatic diseases
2007
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
2007
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
2002
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Statins and hepatotoxicity
2005
Highly sensitive detection of early‐stage pancreatic cancer by multimodal near‐infrared molecular imaging in living mice
2008
Iodinated Contrast Media and the Role of Renal Replacement Therapy
2011
Mechanisms of distal axonal degeneration in peripheral neuropathies
2015
Oxaliplatin‐induced neurotoxicity and the development of neuropathy
2005
Chemotherapy-induced peripheral neurotoxicity
2010
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Current Status on Cholangiocarcinoma and Gallbladder Cancer
2016
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Clinical Management of Oxaliplatin-Associated Neurotoxicity
2005
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
2011
Burden of chemotherapy-induced neuropathy—a cross-sectional study
2010
Transforming activity of the lymphotoxin-β receptor revealed by expression screening
2005
Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma—Epigenetic downregulation of caspases
2008
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen
2011
Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer
2010
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
2011
Pancreatic cancer
2011 Standout
Cellular senescence: from physiology to pathology
2014 Standout
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
2004
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
2006
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review
2011
Chemotherapy for advanced gastric cancer
2017 Standout
Oral Glutamine Is Effective for Preventing Oxaliplatin-Induced Neuropathy in Colorectal Cancer Patients
2007
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
2010
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma
2010
Cancer treatment and survivorship statistics, 2016
2016 Standout
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
2011
Cancer treatment and survivorship statistics, 2019
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis
2007
Toxic Peripheral Neuropathies: Agents and Mechanisms
2019
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
2011
Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Industry sponsorship and research outcome
2017 Standout
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
2009
Genetics of Biliary Tract Cancers and Emerging Targeted Therapies
2010

Works of Florian Eckel being referenced

The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
2000
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
2006
Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
2009
Pancreatic Cancer: Basic and Clinical Aspects
2005
Chemotherapy and Targeted Therapy in Advanced Biliary Tract Carcinoma: A Pooled Analysis of Clinical Trials
2014
Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma
2005
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
2007
Toxicity of a 24-Hour Infusion of Gemcitabine in Biliary Tract and Pancreatic Cancer: A Pilot Study
2002
Volume assessment in patients with necrotizing pancreatitis: A comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water index*
2008
Prophylaxis of Contrast Material–induced Nephropathy in Patients in Intensive Care: Acetylcysteine, Theophylline, or Both? A Randomized Study
2006
Hepatocellular Carcinoma Associated with Hereditary Hemochromatosis Occurring in Non-Cirrhotic Liver
2006
Prevention of Oxaliplatin-Induced Peripheral Sensory Neuropathy by Carbamazepine in Patients with Advanced Colorectal Cancer
2002
Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma
2007
Prevention of peripheral sensory neuropathy (PSN) by carbamazepine in patients with advanced colorectal cancers (ACRC) treated with oxaliplatin. A pilot study
2000
Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review.
2002
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.
2004
Haemodialysis for the Prevention of Contrast-Induced Nephropathy
2002
Pancreatic cancer: a review of recent advances
2006
Rankless by CCL
2026